Informazioni su Artivion, Inc. Common Stock Panoramica della società da Wikipedia

Artivion, Inc. is a distributor of cryogenically preserved human tissues for cardiac and vascular transplant applications and develops medical devices. Among its products are human heart valves, which are treated to remove excess cellular material and antigens, and BioGlue surgical adhesive.

Artivion, Inc. is a distributor of cryogenically preserved human tissues for cardiac and vascular transplant applications and develops medical devices. Among its products are human heart valves, which are treated to remove excess cellular material and antigens, and BioGlue surgical adhesive.

## History

Artivion was founded as CryoLife in Sarasota, Florida in 1984 by Steven Anderson and Robert McNally. Anderson acted as the company’s president and CEO from its founding. The company later moved from Sarasota to the Atlanta metropolitan area. In January 2022 the company changed its name to Artivion, Inc.

In 2000, CryoLife began offering a surgical adhesive called BioGlue used for sealing surgical lacerations under high pressure, such as in arteries.

In February 2008, the FDA gave CryoLife approval for a new kind of heart valve, made from human tissues, which was the first to remove cells from the transplant tissue as opposed to only cleaning the tissue. In giving the approval, the FDA said the new valve, called the CryoValve SynerGraft Pulmonary Valve, had less of a chance of rejection than previous valves.

In 2010, CryoLife acquired the rights to manufacture and distribute PerClot, an absorbable hemostatic powder used in surgery.

In January 2016, the company acquired On-X Life Technologies and its principal product, a mechanical heart valve called the On-X aortic valve replacement, for $130 million.

In October 2017, Artivion acquired JOTEC GmbH, a German-based developer of medical devices for aortic and peripheral vascular diseases, for €225 million. In September 2020, the company acquired Ascyrus Medical.

In 2021, the company received FDA premarket application approval of its PerClot absorbable hemostatic system, which comprised PerClot granules and a delivery system for surgical use. Baxter International agreed to buy PerClot from Artivion in 2021. In 2023, after final FDA approval of the product, the purchase was completed.

Fonte: Wikipedia (Inglese), CC BY-SA 4.0 · Vedi su Wikipedia ↗

Wikidata ↗

AORT Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

Prezzo

$29.85

Capitalizzazione di Mercato

$1.49B

P/E (TTM)

144.0

EPS (TTM)

$0.21

Ricavi (TTM)

$441M

Rendimento div.

—

ROE

2.2%

D/E Debito/Patrimonio

0.5

Intervallo 52 sett.

$19 – $48

AORT Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

Performance decennale Andamento di ricavi, utile netto, margini e EPS

Ricavi e Utile Netto $441M

2016-12-31 → 2025-12-31

EPS $0.21

2016-12-31 → 2025-12-31

Flusso di cassa libero $839.0K

2016-12-31 → 2025-12-31

Margini 2.2%

2016-12-31 → 2025-12-31

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Metrica

Tendenza 5 anni

AORT

Mediana dei peer

P/E (TTM)

144.0

38.5

P/S (TTM)

3.4

2.5

P/B

3.3

4.8

EV / EBITDA

29.2

—

Price / FCF (Prezzo / FCF)

1778.3

—

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Metrica

Tendenza 5 anni

AORT

Mediana dei peer

Gross Margin (Margine lordo)

64.4%

58.7%

Operating Margin (Margine Operativo)

7.6%

—

Net Profit Margin (Margine di Profitto Netto)

2.2%

-12.6%

ROA

1.2%

-11.8%

ROE

2.2%

-37.7%

ROIC

3.4%

—

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Metrica

Tendenza 5 anni

AORT

Mediana dei peer

Debt / Equity (Debito / Patrimonio Netto)

0.5

25.5

Current Ratio (Rapporto corrente)

3.5

Quick Ratio

1.5

—

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metrica

Tendenza 5 anni

AORT

Mediana dei peer

Revenue YoY (Ricavi YoY)

13.6%

—

Revenue CAGR 3Y (CAGR Ricavi 3Y)

12.0%

—

Revenue CAGR 5Y (CAGR Ricavi 5Y)

11.8%

—

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Metrica

Tendenza 5 anni

AORT

Mediana dei peer

EPS (Diluted) (EPS (Diluito))

$0.21

—

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

Metrica

Tendenza 5 anni

AORT

Mediana dei peer

Dividendi Rendimento, payout ratio, storico dividendi, CAGR 5Y

Dividend Yield

—

Rapporto di Distribuzione Utili

—

CAGR Dividendi 5Y

—

Data ex-dividendo	Importo
09 Dicembre 2015	$0,0300
09 Settembre 2015	$0,0300
10 Giugno 2015	$0,0300
11 Marzo 2015	$0,0300
10 Dicembre 2014	$0,0300
10 Settembre 2014	$0,0300
11 Giugno 2014	$0,0300
12 Marzo 2014	$0,0280
11 Dicembre 2013	$0,0280
11 Settembre 2013	$0,0280
12 Giugno 2013	$0,0280
12 Marzo 2013	$0,0250
12 Dicembre 2012	$0,0250
12 Settembre 2012	$0,0250

AORT Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

COMPRA 14 analisti

Acquisto forte 5 35,7%
Compra 8 57,1%
Mantieni 1 7,1%
Vendi 0 0,0%
Vendita forte 0 0,0%

Target Price a 12 Mesi

8 analisti · 2026-08-18

Mediana $42.00

← Sotto tutti i target $29.85

Basso $38.00

Alto $48.00

Target mediano $42.00 +40,7%

Target medio $42.15 +41,2%

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

Sorpresa media

-0.02%

Periodo	EPS Actual	EPS Stimato	Sorpresa
30 Giugno 2026	$-0.28	$0.01	-0.29%
31 Marzo 2026	$0.03	$0.05	-0.02%
31 Dicembre 2025	$0.05	$0.08	-0.03%
30 Settembre 2025	$0.06	$0.02	0.04%
30 Giugno 2025	$0.08	$-0.00	0.08%
31 Marzo 2025	$-0.01	$-0.12	0.11%

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

Ticker	Capitalizzazione di Mercato	P/E	Rev YoY	Margine Netto	ROE	Margine lordo
AORT	$2.25B	217.2	13.6%	2.2%	2.2%	64.4%
TNDM	$1.50B	-7.2	7.9%	-20.2%	-141.9%	53.8%
CNMD	$1.27B	26.9	5.2%	3.4%	4.6%	54.6%
ATEC	$3.16B	-21.9	24.9%	-18.8%	-792.1%	69.6%
ENOV	$1.52B	-1.3	6.7%	-52.7%	-58.5%	59.8%
IART	—	-1.8	1.5%	-31.6%	-49.6%	—
KMTS	$1.21B	-8.5	59.0%	-138.4%	-62.1%	51.4%
PRCT	$1.77B	-18.3	37.2%	-31.0%	-25.4%	63.7%
IRMD	$1.24B	55.6	14.4%	26.8%	23.8%	76.8%
ABT	$250.18B	33.7	5.7%	14.7%	13.1%	—

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

Conto Economico 18

Dati annuali Conto Economico per AORT
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue	$441M	$389M	$354M	$314M	$299M	$253M	$276M	$263M	$190M	$180M	$146M	$145M
Cost of Revenue	$157M	$140M	$125M	$111M	$101M	$85M	$93M	$90M	$61M	$61M	$55M	$53M
Gross Profit	$284M	$249M	$229M	$203M	$198M	$168M	$183M	$173M	$129M	$119M	$91M	$91M
R&D Expense	$31M	$28M	$29M	$39M	$36M	$24M	$23M	$23M	$19M	$13M	$10M	$9M
SG&A Expense	$226M	$181M	$209M	$157M	$170M	$141M	$143M	$141M	$101M	$92M	$75M	$74M
Operating Expenses	$257M	$210M	$238M	$196M	$205M	$165M	$166M	$164M	$121M	$105M	$85M	$82M
Operating Income	$34M	$39M	$6M	$6M	$8M	$2M	$17M	$9M	$8M	$22M	$5M	$9M
Interest Expense	·	·	$25M	$18M	$17M	$17M	$15M	$16M	$5M	$3M	$62.0K	$175.0K
Interest Income	$763.0K	$1M	$1M	$147.0K	$79.0K	$217.0K	$738.0K	$226.0K	$212.0K	$72.0K	$45.0K	$50.0K
Other Non-op	$10M	$-10M	$-3M	$-3M	$-6M	$-3M	$-1M	$-141.0K	$260.0K	$-437.0K	$-484.0K	$-540.0K
Pretax Income	$15M	$-8M	$-22M	$-15M	$-15M	$-17M	$2M	$-6M	$4M	$18M	$6M	$9M
Income Tax	$5M	$6M	$9M	$4M	$7.0K	$-492.0K	$-76.0K	$-4M	$-143.0K	$8M	$2M	$1M
Net Income	$10M	$-13M	$-31M	$-19M	$-15M	$-17M	$2M	$-3M	$4M	$11M	$4M	$7M
EPS (Basic)	$0.22	$-0.32	$-0.75	$-0.48	$-0.38	$-0.44	$0.05	$-0.08	$0.11	$0.33	$0.14	$0.26
EPS (Diluted)	$0.21	$-0.32	$-0.75	$-0.48	$-0.38	$-0.44	$0.05	$-0.08	$0.11	$0.32	$0.14	$0.25
Shares (Basic)	45,335,000	41,676,000	40,743,000	40,032,000	38,983,000	37,861,000	37,118,000	36,412,000	33,008,000	31,855,000	27,744,000	27,379,000
Shares (Diluted)	47,162,000	41,676,000	40,743,000	40,032,000	38,983,000	37,861,000	37,860,000	36,412,000	34,163,000	32,822,000	28,542,000	28,313,000
EBITDA	$56M	$63M	$29M	$29M	$32M	$23M	$35M	$27M	$18M	$30M	·	$15M

Stato Patrimoniale 28

Dati annuali Stato Patrimoniale per AORT
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Cash & Equivalents	$65M	$53M	$59M	$39M	$55M	$61M	$34M	$41M	$40M	$57M	$38M	$33M
Receivables	$90M	$79M	$72M	$62M	$53M	$46M	$53M	$47M	$48M	$28M	$23M	$21M
Inventory	$92M	$80M	$82M	$74M	$77M	$73M	$53M	$45M	$47M	$26M	$15M	$13M
Prepaid Expense	$43M	$19M	$16M	$18M	$15M	$14M	$12M	$7M	$5M	$3M	$5M	$5M
Current Assets	$358M	$290M	$281M	$247M	$248M	$235M	$187M	$179M	$179M	$147M	$110M	$106M
PP&E (Net)	$65M	$36M	$38M	$39M	$38M	$33M	$32M	$31M	$34M	$19M	$11M	$12M
PP&E (Gross)	·	·	·	$127M	$120M	$111M	$103M	$96M	$93M	$74M	$64M	$62M
Accum. Depreciation	·	·	·	$88M	$82M	$78M	$71M	$65M	$60M	$55M	$53M	$50M
Goodwill	$254M	$241M	$247M	$244M	$250M	$260M	$187M	$189M	$188M	$78M	$11M	$11M
Intangibles	$124M	$128M	$143M	$151M	$167M	$186M	$115M	$118M	$130M	$1M	$1M	$2M
Other Non-current Assets	$15M	$24M	$9M	$7M	$8M	$15M	$14M	$8M	$7M	$2M	$6M	$5M
Total Assets	$885M	$789M	$792M	$763M	$793M	$789M	$606M	$571M	$590M	$316M	$181M	$176M
Accounts Payable	$16M	$18M	$13M	$12M	$10M	$10M	$10M	$8M	$10M	$6M	$5M	$4M
Accrued Liabilities	$16M	$12M	$10M	$12M	$8M	$7M	$7M	$7M	$12M	$5M	$3M	$3M
Current Liabilities	$102M	$67M	$58M	$50M	$45M	$60M	$45M	$35M	$43M	$30M	$20M	$21M
Capital Leases	$34M	$40M	$44M	$41M	$45M	$14M	$18M	$0	$7M	$11.0K	·	·
Deferred Tax	$24M	$20M	$22M	$24M	$29M	$35M	$26M	$27M	$30M	$7.0K	·	·
Other Non-current Liabilities	$9M	$8M	$7M	$7M	$6M	$7M	$7M	$7M	$8M	$5M	$3M	$3M
Total Liabilities	$437M	$513M	$511M	$478M	$492M	$461M	$320M	$296M	$313M	$107M	$26M	$27M
Long-term Debt	$215M	$314M	$307M	$308M	$309M	$292M	$216M	$217M	$219M	$72M	·	·
Total Debt	$215M	$314M	$307M	$308M	$309M	$292M	$216M	$217M	$219M	$72M	·	·
Common Stock	$493.0K	$434.0K	$426.0K	$418.0K	$414.0K	$404.0K	$390.0K	$385.0K	$376.0K	$342.0K	$298.0K	$292.0K
Retained Earnings	$-51M	$-61M	$-48M	$-17M	$2M	$20M	$37M	$35M	$38M	$34M	$23M	$23M
Treasury Stock	$15M	$15M	$15M	$15M	$15M	$15M	$15M	$15M	$13M	$12M	$11M	$9M
AOCI	$-3M	$-25M	$-12M	$-22M	$-10M	$7M	$-9M	$-6M	$2M	$-429.0K	$-76.0K	$-121.0K
Stockholders' Equity	$448M	$276M	$282M	$284M	$301M	$329M	$286M	$275M	$277M	$209M	$155M	$149M
Liabilities + Equity	$885M	$789M	$792M	$763M	$793M	$789M	$606M	$571M	$590M	$316M	$181M	$176M
Shares Outstanding	49,330,000	43,432,000	42,569,000	41,830,000	41,397,000	40,394,000	39,018,000	38,463,000	37,618,000	34,230,000	29,766,000	29,229,000

Flusso di cassa 19

Dati annuali Flusso di cassa per AORT
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
D&A	$22M	$24M	$23M	$22M	$24M	$21M	$18M	$18M	$10M	$8M	$6M	$6M
Stock-based Comp	$24M	$14M	$14M	$12M	$11M	$7M	$9M	$6M	$7M	$6M	$5M	$3M
Deferred Tax	$37.0K	$-2M	$-1M	$-885.0K	$-6M	$816.0K	$-2M	$-6M	$-1M	$3M	$1M	$173.0K
Amort. of Intangibles	$14M	$16M	$15M	$15M	$17M	$14M	$11M	$11M	$5M	$4M	$2M	$2M
Other Non-cash	$-17M	$-1M	$13M	$-20M	$-17M	$611.0K	$-11M	$-5M	$-8M	$-8M	·	$-9M
Operating Cash Flow	$40M	$22M	$19M	$-5M	$-3M	$12M	$16M	$10M	$11M	$20M	$11M	$8M
CapEx	$39M	$11M	$10M	$11M	$13M	$7M	$8M	$6M	$7M	$6M	$3M	$4M
Investing Cash Flow	$-42M	$-28M	$-502.0K	$-11M	$6M	$-73M	$-24M	$-7M	$-171M	$-79M	$-4M	·
Debt Issued	$0	$184M	$0	$0	·	·	·	·	·	·	·	·
Net Debt Issued	$-210.0K	$-28M	$-3M	·	·	·	·	·	·	·	·	·
Stock Issued	$13M	$6M	$4M	$3M	$4M	$2M	$5M	$4M	$3M	$2M	$2M	$3M
Stock Repurchased	·	·	·	·	·	·	·	·	·	·	·	$6M
Net Stock Activity	$13M	$6M	$4M	$3M	$4M	$2M	$5M	$4M	$3M	$2M	·	$-3M
Dividends Paid	·	·	·	·	·	·	·	·	·	·	$3M	$3M
Financing Cash Flow	$11M	$2M	$865.0K	$-2M	$-12M	$94M	$-1M	$-3M	$143M	$73M	$-3M	·
Net Change in Cash	$11M	$-5M	$20M	$-16M	$-7M	$28M	$-8M	$1M	$-17M	$14M	$4M	$-4M
Taxes Paid	$3M	·	·	·	·	·	·	·	·	·	$145.0K	$3M
Free Cash Flow	$839.0K	$11M	$11M	$-14M	$-16M	$5M	$8M	$4M	$4M	$14M	·	$4M
Levered FCF	·	·	$-25M	$-38M	$-33M	$-11M	$-8M	$-3M	$-925.8K	$12M	·	·

Redditività 8

Dati annuali Redditività per AORT
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Gross Margin	64.4%	64.0%	64.7%	64.5%	66.1%	66.3%	66.3%	65.8%	67.8%	65.9%	·	63.1%
Operating Margin	7.6%	10.0%	1.6%	2.0%	2.7%	0.96%	6.2%	3.5%	4.2%	12.1%	·	6.1%
Net Margin	2.2%	-3.4%	-8.7%	-6.1%	-5.0%	-6.6%	0.62%	-1.1%	1.9%	6.0%	·	5.1%
Pretax Margin	3.4%	-1.9%	-6.1%	-4.8%	-5.0%	-6.8%	0.60%	-2.4%	1.9%	10.2%	·	6.0%
EBITDA Margin	12.7%	16.2%	8.1%	9.1%	10.7%	9.1%	12.8%	10.4%	9.3%	16.7%	·	10.3%
ROA	1.2%	-1.7%	-4.0%	-2.5%	-1.9%	-2.4%	0.29%	-0.49%	0.82%	4.3%	·	4.2%
ROE	2.2%	-4.6%	-11.1%	-7.1%	-4.9%	-5.1%	0.61%	-1.0%	1.5%	5.9%	·	5.0%
ROIC	3.4%	11.7%	1.4%	1.3%	1.3%	0.38%	3.6%	0.84%	1.7%	4.5%	·	5.0%

Liquidità e Solvibilità 5

Dati annuali Liquidità e Solvibilità per AORT
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Current Ratio	3.5	4.3	4.9	5.0	5.5	3.9	4.1	5.2	4.2	4.9	·	5.1
Quick Ratio	1.5	2.0	2.3	2.0	2.4	1.8	1.9	2.6	2.0	2.8	·	2.6
Debt / Equity	0.5	1.1	1.1	1.1	1.0	0.9	0.8	0.8	0.8	0.3	·	·
LT Debt / Equity	0.5	1.1	1.1	1.1	1.0	0.9	0.8	0.8	0.8	0.3	·	·
Interest Coverage	·	·	0.2	0.3	0.5	0.1	1.1	0.6	1.6	7.3	·	·

Efficienza 3

Dati annuali Efficienza per AORT
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Asset Turnover	0.5	0.5	0.5	0.4	0.4	0.4	0.5	0.5	0.4	0.7	·	0.8
Inventory Turnover	1.8	1.7	1.6	1.5	1.4	1.4	1.9	1.9	1.7	3.0	·	4.7
Receivables Turnover	5.2	5.1	5.3	5.5	6.0	5.1	5.5	5.6	5.0	7.0	·	7.4

Per Azione 7

Dati annuali Per Azione per AORT
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Book Value / Share	$9.09	$6.36	$6.62	$6.80	$7.26	$8.14	$7.32	$7.15	$7.37	$6.11	·	$5.09
Revenue / Share	$9.36	$9.32	$8.69	$7.84	$7.67	$6.69	$7.30	$7.22	$5.55	$5.50	·	$5.11
Cash Flow / Share	$0.85	$0.53	$0.46	$-0.13	$-0.07	$0.33	$0.42	$0.27	$0.32	$0.60	·	$0.29
Cash / Share	$1.32	$1.23	$1.38	$0.94	$1.33	$1.52	$0.87	$1.08	$1.06	$1.65	·	$1.14
Dividend / Share	·	·	·	·	·	·	$0	$0	$0	$0	$0	$0
Dividend Paid / Share	·	·	·	·	·	·	·	·	·	·	$0	$0
EPS (TTM)	$0.21	$-0.32	$-0.75	$-0.48	$-0.38	$-0.44	$0.05	$-0.08	$0.11	$0.32	$0.14	$0.25

Tassi di Crescita 3

Dati annuali Tassi di Crescita per AORT
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue YoY	13.6%	9.8%	12.8%	5.0%	18.0%	·	·	·	·	·	·	·
Revenue CAGR 3Y	12.0%	9.1%	11.8%	·	·	·	·	·	·	·	·	·
Revenue CAGR 5Y	11.8%	·	·	·	·	·	·	·	·	·	·	·

Valutazione (TTM) 17

Dati annuali Valutazione (TTM) per AORT
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue TTM	$441M	$389M	$354M	$314M	$299M	$253M	$276M	$263M	$190M	$180M	$146M	$145M
Net Income TTM	$10M	$-13M	$-31M	$-19M	$-15M	$-17M	$2M	$-3M	$4M	$11M	$4M	$7M
Market Cap	$2.25B	$1.24B	$761M	$507M	$842M	$954M	$1.06B	$1.09B	$720M	$656M	·	$331M
Enterprise Value	$2.40B	$1.50B	$1.01B	$776M	$1.10B	$1.18B	$1.24B	$1.27B	$899M	$670M	·	·
P/E	217.2	-89.3	-23.8	-25.2	-53.6	-53.7	541.8	-354.8	174.1	59.8	77.0	45.3
P/S	5.1	3.2	2.2	1.6	2.8	3.8	3.8	4.2	3.8	3.6	·	2.3
P/B	5.0	4.5	2.7	1.8	2.8	2.9	3.7	4.0	2.6	3.1	·	2.2
P / Tangible Book	31.9	·	·	·	·	·	·	·	·	·	·	·
P / Cash Flow	56.4	55.8	40.4	-98.4	-325.9	77.1	66.8	110.5	66.7	33.2	·	40.8
P / FCF	2681.7	112.4	66.8	-35.8	-53.7	189.2	136.3	266.6	172.7	48.5	·	87.0
EV / EBITDA	42.7	23.8	35.0	27.1	34.2	51.1	35.0	46.2	50.8	22.2	·	·
EV / FCF	2860.7	136.0	88.6	-54.7	-70.0	234.9	159.8	309.4	215.6	49.6	·	·
EV / Revenue	5.4	3.9	2.9	2.5	3.7	4.7	4.5	4.8	4.7	3.7	·	·
Dividend Yield	·	·	·	·	·	·	·	·	·	·	·	0.99%
Earnings Yield	0.46%	-1.1%	-4.2%	-4.0%	-1.9%	-1.9%	0.18%	-0.28%	0.57%	1.7%	1.3%	2.2%
Payout Ratio	·	·	·	·	·	·	·	·	·	·	·	45.0%
Annual Payout	·	·	·	·	·	·	·	·	·	·	$3M	$3M

Conto Economico 18

Dati trimestrali Conto Economico per AORT
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$126M	$116M	$116M	$113M	$113M	$99M	$97M	$96M	$98M	$97M	$94M	$88M	$89M	$83M	$79M	$77M
Cost of Revenue	$45M	$41M	$43M	$39M	$40M	$35M	$36M	$35M	$35M	$34M	$33M	$32M	$31M	$30M	$29M	$28M
Gross Profit	$81M	$75M	$73M	$74M	$73M	$64M	$62M	$61M	$63M	$63M	$61M	$56M	$58M	$54M	$51M	$49M
R&D Expense	$9M	$9M	$9M	$8M	$7M	$7M	$7M	$7M	$7M	$7M	$8M	$6M	$7M	$7M	$8M	$12M
SG&A Expense	$80M	$61M	$57M	$57M	$58M	$55M	$51M	$50M	$49M	$31M	$50M	$51M	$57M	$50M	$38M	$41M
Operating Expenses	$89M	$70M	$66M	$65M	$65M	$61M	$59M	$57M	$57M	$38M	$58M	$58M	$65M	$58M	$47M	$53M
Operating Income	$-8M	$6M	$11M	$13M	$8M	$2M	$3M	$4M	$7M	$25M	$3M	$-1M	$8M	$-4M	$4M	$-4M
Interest Expense	·	·	·	·	·	·	·	·	·	$8M	·	$7M	$6M	$6M	·	$5M
Interest Income	$367.0K	$205.0K	$311.0K	$240.0K	$68.0K	$144.0K	$374.0K	$366.0K	$353.0K	$374.0K	$398.0K	$339.0K	$265.0K	$75.0K	$61.0K	$40.0K
Other Non-op	$4M	$-286.0K	$1M	$399.0K	$5M	$3M	$-10M	$2M	$-983.0K	$-1M	$2M	$-2M	$-4M	$963.0K	$4M	$-4M
Pretax Income	$-12M	$339.0K	$7M	$7M	$3M	$-2M	$-17M	$-1M	$-2M	$13M	$-591.0K	$-9M	$-3M	$-9M	$3M	$-13M
Income Tax	$2M	$-1M	$4M	$554.0K	$2M	$-2M	$-119.0K	$1M	$-306.0K	$5M	$3M	$382.0K	$725.0K	$5M	$1M	$1M
Net Income	$-14M	$1M	$2M	$7M	$1M	$-505.0K	$-16M	$-2M	$-2M	$8M	$-4M	$-10M	$-3M	$-14M	$2M	$-14M
EPS (Basic)	$-0.28	$0.03	$0.06	$0.14	$0.03	$-0.01	$-0.40	$-0.05	$-0.05	$0.18	$-0.10	$-0.24	$-0.08	$-0.33	$0.05	$-0.34
EPS (Diluted)	$-0.28	$0.03	$0.06	$0.13	$0.03	$-0.01	$-0.40	$-0.05	$-0.05	$0.18	$-0.10	$-0.24	$-0.08	$-0.33	$0.05	$-0.34
Shares (Basic)	48,541,000	48,074,000	-88,426,000	47,233,000	44,296,000	42,232,000	-83,141,000	41,844,000	41,683,000	41,290,000	-81,325,000	40,881,000	40,755,000	40,432,000	-79,964,000	40,115,000
Shares (Diluted)	48,541,000	49,731,000	-89,223,000	48,775,000	45,378,000	42,232,000	-89,737,000	41,844,000	41,683,000	47,886,000	-81,325,000	40,881,000	40,755,000	40,432,000	-79,964,000	40,115,000
EBITDA	$-8M	$12M	·	$13M	$8M	$8M	·	$4M	$7M	$31M	·	$-1M	$8M	$2M	·	$-4M

Stato Patrimoniale 26

Dati trimestrali Stato Patrimoniale per AORT
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$77M	$56M	$65M	$73M	$53M	$38M	$53M	$56M	$55M	$51M	·	$53M	$49M	$31M	·	$38M
Receivables	$98M	$92M	$90M	$88M	$91M	$88M	$79M	$76M	$74M	$74M	·	$64M	$65M	$63M	·	$57M
Inventory	$103M	$98M	$92M	$91M	$87M	$82M	$80M	$84M	$81M	$82M	·	$79M	$78M	$76M	·	$73M
Prepaid Expense	$27M	$45M	$43M	$22M	$25M	$20M	$19M	$19M	$20M	$17M	·	$17M	$19M	$20M	·	$17M
Current Assets	$371M	$358M	$358M	$337M	$319M	$287M	$290M	$288M	$285M	$277M	·	$267M	$264M	$241M	·	$238M
PP&E (Net)	$74M	$68M	$65M	$41M	$40M	$38M	$36M	$38M	$37M	$38M	·	$37M	$38M	$39M	·	$36M
Goodwill	$350M	$252M	$254M	$254M	$254M	$245M	$241M	$249M	$244M	$245M	$247M	$243M	$246M	$246M	$244M	$235M
Intangibles	$149M	$120M	$124M	$126M	$129M	$128M	$128M	$135M	$135M	$138M	·	$143M	$147M	$150M	·	$148M
Other Non-current Assets	$15M	$16M	$15M	$29M	$27M	$25M	$24M	$21M	$14M	$13M	·	$8M	$8M	$8M	·	$7M
Total Assets	$1.07B	$883M	$885M	$858M	$838M	$791M	$789M	$803M	$790M	$784M	·	$775M	$778M	$757M	·	$743M
Accounts Payable	$21M	$18M	$16M	$16M	$19M	$12M	$18M	$11M	$12M	$10M	·	$11M	$10M	$9M	·	$11M
Accrued Liabilities	$16M	$17M	$16M	$12M	$11M	$12M	$12M	$16M	$16M	$16M	·	$10M	$10M	$10M	·	$10M
Current Liabilities	$107M	$93M	$102M	$86M	$67M	$52M	$67M	$153M	$51M	$46M	·	$55M	$56M	$44M	·	$46M
Capital Leases	$36M	$34M	$34M	$38M	$39M	$39M	$40M	$41M	$42M	$43M	·	$43M	$40M	$41M	·	$41M
Deferred Tax	$26M	$28M	$24M	$22M	$23M	$22M	$20M	$19M	$22M	$22M	·	$20M	$19M	$24M	·	$34M
Other Non-current Liabilities	$9M	$9M	$9M	$9M	$9M	$8M	$8M	$8M	$8M	$8M	·	$8M	$7M	$7M	·	$7M
Total Liabilities	$626M	$433M	$437M	$419M	$418M	$497M	$513M	$498M	$494M	$489M	·	$503M	$495M	$477M	·	$488M
Long-term Debt	$363M	$215M	$215M	$215M	$216M	$315M	$314M	$314M	$314M	$313M	·	$307M	$308M	$308M	·	$308M
Total Debt	$363M	$215M	·	$215M	$216M	$315M	·	$314M	$314M	$313M	·	$307M	$308M	$308M	·	$308M
Common Stock	$502.0K	$500.0K	$493.0K	$488.0K	$486.0K	$442.0K	$434.0K	$434.0K	$433.0K	$432.0K	·	$425.0K	$424.0K	$424.0K	·	$418.0K
Retained Earnings	$-64M	$-50M	$-51M	$-54M	$-60M	$-62M	$-61M	$-45M	$-42M	$-40M	·	$-44M	$-34M	$-31M	·	$-19M
Treasury Stock	$15M	$15M	$15M	$15M	$15M	$15M	$15M	$15M	$15M	$15M	·	$15M	$15M	$15M	·	$15M
AOCI	$-12M	$-12M	$-3M	$-2M	$-3M	$-19M	$-25M	$-10M	$-16M	$-14M	·	$-21M	$-16M	$-18M	·	$-45M
Stockholders' Equity	$446M	$450M	$448M	$439M	$420M	$294M	$276M	$305M	$295M	$295M	$282M	$272M	$283M	$280M	$284M	$255M
Liabilities + Equity	$1.07B	$883M	$885M	$858M	$838M	$791M	$789M	$803M	$790M	$784M	·	$775M	$778M	$757M	·	$743M
Shares Outstanding	50,179,000	49,983,000	49,330,000	48,862,000	48,592,000	44,190,000	43,432,000	43,392,000	·	·	42,569,000	42,537,000	42,443,000	42,366,000	41,830,000	41,816,000

Flusso di cassa 16

Dati trimestrali Flusso di cassa per AORT
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
D&A	$7M	$6M	$6M	$6M	$6M	$5M	$6M	$6M	$6M	$6M	$6M	$6M	$6M	$6M	$5M	$6M
Stock-based Comp	$8M	$8M	$4M	$6M	$6M	$8M	$3M	$4M	$4M	$3M	$4M	$3M	$4M	$3M	$3M	$3M
Deferred Tax	·	·	·	·	·	·	$3M	·	·	·	$6M	·	·	·	·	·
Amort. of Intangibles	$4M	$4M	$3M	$3M	$3M	$3M	$4M	$4M	$4M	$4M	$4M	$4M	$4M	$4M	$4M	$4M
Other Non-cash	·	$-15M	·	·	·	$-30M	·	·	·	$-22M	·	·	·	$-2M	·	·
Operating Cash Flow	$-1M	$1M	$20M	$22M	$15M	$-17M	$10M	$11M	$6M	$-5M	$11M	$7M	$7M	$-6M	$-217.0K	$4M
CapEx	$11M	$8M	$28M	$5M	$3M	$4M	$1M	$4M	$3M	$4M	$3M	$3M	$3M	$3M	$4M	$3M
Investing Cash Flow	$-129M	$-11M	$-31M	$-5M	$-3M	$-4M	$-11M	$-11M	$-3M	$-4M	$-3M	$-2M	$7M	$-3M	$-3M	$-3M
Debt Issued	·	·	$0	$0	$0	$0	$-6M	$160M	$160M	$190M	$0	$0	$0	$0	·	·
Net Debt Issued	·	$0	·	·	·	$-66.0K	·	·	·	$-182M	·	·	·	·	·	·
Stock Issued	$1M	$1M	$3M	$5M	$278.0K	$4M	$443.0K	$2M	$59.0K	$4M	$488.0K	$886.0K	$0	$3M	$24.0K	$1M
Net Stock Activity	·	$1M	·	·	·	$4M	·	·	·	$4M	·	·	·	$3M	·	·
Financing Cash Flow	$152M	$463.0K	$2M	$2M	$3M	$4M	$174.0K	$1M	$-181.0K	$737.0K	$-2M	$-909.0K	$2M	$1M	$-859.0K	$252.0K
Net Change in Cash	$22M	$-9M	$-9M	$20M	$16M	$-16M	$-3M	$1M	$4M	$-8M	$5M	$5M	$18M	$-9M	$2M	$-3M
Free Cash Flow	·	$-7M	·	·	·	$-21M	·	·	·	$-9M	·	·	·	$-8M	·	·
Levered FCF	·	·	·	·	·	·	·	·	·	$-14M	·	·	·	$-18M	·	·

Redditività 8

Dati trimestrali Redditività per AORT
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Gross Margin	64.0%	64.8%	·	65.6%	64.7%	64.2%	·	63.7%	64.6%	64.6%	·	64.0%	65.1%	64.5%	·	63.4%
Operating Margin	-6.7%	5.0%	·	11.1%	7.4%	2.2%	·	4.6%	6.6%	26.0%	·	-1.4%	8.6%	-4.6%	·	-5.3%
Net Margin	-10.7%	1.2%	·	5.7%	1.2%	-0.51%	·	-2.4%	-2.2%	7.7%	·	-11.2%	-3.8%	-16.3%	·	-17.8%
Pretax Margin	-9.3%	0.29%	·	6.2%	3.1%	-2.3%	·	-1.3%	-2.5%	13.1%	·	-10.7%	-3.0%	-10.7%	·	-16.3%
EBITDA Margin	-6.7%	10.4%	·	11.1%	7.4%	7.7%	·	4.6%	6.6%	32.0%	·	-1.4%	8.6%	2.2%	·	-5.3%
ROA	-1.4%	0.17%	·	0.78%	0.17%	-0.06%	·	-0.29%	-0.27%	0.98%	·	-1.3%	-0.44%	-1.8%	·	-1.8%
ROE	-3.1%	0.38%	·	1.8%	0.38%	-0.17%	·	-0.79%	-0.73%	2.6%	·	-3.7%	-1.2%	-4.7%	·	-4.8%
ROIC	-1.2%	3.6%	·	1.8%	0.51%	0.08%	·	1.3%	0.93%	2.5%	·	-0.22%	1.7%	-1.0%	·	-0.80%

Liquidità e Solvibilità 5

Dati trimestrali Liquidità e Solvibilità per AORT
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio	3.5	3.9	·	3.9	4.8	5.5	·	1.9	5.6	6.0	·	4.9	4.7	5.5	·	5.2
Quick Ratio	1.6	1.6	·	1.9	2.2	2.4	·	0.9	2.5	2.7	·	2.1	2.0	2.1	·	2.1
Debt / Equity	0.8	0.5	·	0.5	0.5	1.1	·	1.0	1.1	1.1	·	1.1	1.1	1.1	·	1.2
LT Debt / Equity	0.8	0.5	·	0.5	0.5	1.1	·	0.7	1.1	1.1	·	1.1	1.1	1.1	·	1.2
Interest Coverage	·	·	·	·	·	·	·	·	·	3.2	·	-0.2	1.2	-0.6	·	-0.9

Efficienza 3

Dati trimestrali Efficienza per AORT
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover	0.1	0.1	·	0.1	0.1	0.1	·	0.1	0.1	0.1	·	0.1	0.1	0.1	·	0.1
Inventory Turnover	0.5	0.5	·	0.4	0.5	0.4	·	0.4	0.4	0.4	·	0.4	0.4	0.4	·	0.4
Receivables Turnover	1.3	1.3	·	1.4	1.4	1.2	·	1.4	1.4	1.4	·	1.4	1.5	1.4	·	1.4

Per Azione 5

Dati trimestrali Per Azione per AORT
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	$8.88	$9.01	·	$8.98	$8.64	$6.66	·	$7.02	·	·	·	$6.39	$6.66	$6.61	·	$6.10
Revenue / Share	$2.59	$2.34	·	$2.32	$2.49	$2.34	·	$2.29	$2.35	$2.03	·	$2.15	$2.19	$2.06	·	$1.92
Cash Flow / Share	·	$0.02	·	·	·	$-0.40	·	·	·	$-0.11	·	·	·	$-0.15	·	·
Cash / Share	$1.54	$1.12	·	$1.50	$1.10	$0.85	·	$1.29	·	·	·	$1.26	$1.15	$0.73	·	$0.90
EPS (TTM)	$-0.09	$0.18	·	$0.10	$-0.08	$0.07	·	$-0.16	$-0.19	$-0.47	·	$-0.99	$-0.86	$-0.86	·	$-0.27

Valutazione (TTM) 14

Dati trimestrali Valutazione (TTM) per AORT
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$468M	$442M	·	$421M	$406M	$390M	·	$379M	$373M	$358M	·	$337M	$330M	$318M	·	$307M
Net Income TTM	$-4M	$9M	·	$5M	$-4M	$3M	·	$-7M	$-8M	$-19M	·	$-40M	$-35M	$-35M	·	$-11M
Market Cap	$1.13B	$1.83B	·	$2.07B	$1.51B	$1.09B	·	$1.16B	·	·	·	$645M	$730M	$555M	·	$579M
Enterprise Value	$1.41B	$1.99B	·	$2.21B	$1.67B	$1.36B	·	$1.41B	·	·	·	$899M	$988M	$832M	·	$849M
P/E	-249.7	203.4	·	423.4	-388.8	351.1	·	-166.4	-135.0	-45.0	·	-15.3	-20.0	-15.2	·	-51.3
P/S	2.4	4.1	·	4.9	3.7	2.8	·	3.0	·	·	·	1.9	2.2	1.7	·	1.9
P/B	2.5	4.1	·	4.7	3.6	3.7	·	3.8	·	·	·	2.4	2.6	2.0	·	2.3
P / Tangible Book	·	23.2	·	35.5	41.0	·	·	·	·	·	·	·	·	·	·	·
P / Cash Flow	·	1586.1	·	·	·	-64.1	·	·	·	·	·	·	·	-90.2	·	·
P / FCF	·	-267.2	·	·	·	-52.8	·	·	·	·	·	·	·	-66.1	·	·
EV / EBITDA	-169.0	164.1	·	176.3	199.6	179.6	·	322.1	·	·	·	-722.5	128.8	444.3	·	-206.9
EV / FCF	·	-290.5	·	·	·	-66.2	·	·	·	·	·	·	·	-99.2	·	·
EV / Revenue	3.0	4.5	·	5.2	4.1	3.5	·	3.7	·	·	·	2.7	3.0	2.6	·	2.8
Earnings Yield	-0.40%	0.49%	·	0.24%	-0.26%	0.28%	·	-0.60%	-0.74%	-2.2%	·	-6.5%	-5.0%	-6.6%	·	-1.9%

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

Conto Economico

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Ricavi	$441M	$389M	$354M	$314M	$299M
Margine Lordo %	64.4%	64.0%	64.7%	64.5%	66.1%
Margine Operativo %	7.6%	10.0%	1.6%	2.0%	2.7%
Utile netto	$10M	$-13M	$-31M	$-19M	$-15M
EPS Diluito	$0.21	$-0.32	$-0.75	$-0.48	$-0.38

Stato Patrimoniale

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Debito / Patrimonio Netto	0.5	1.1	1.1	1.1	1.0
Rapporto corrente	3.5	4.3	4.9	5.0	5.5
Quick Ratio	1.5	2.0	2.3	2.0	2.4

Flusso di cassa

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Flusso di cassa libero	$839.0K	$11M	$11M	$-14M	$-16M

Ultime notizie Notizie recenti che menzionano questa società

Opzioni di titolo entro le linee guida editoriali: Un ETF Shop ha reso il suo titolo principale un medtech battuto Nasdaq · 3 mesi fa
Catalizzatori Forti Guidano Artivion (AORT) Yahoo Finance · 3 mesi, 3 settimane fa

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

📊

Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.

La tua selezione è salvata e ti segue su tutti i ticker.

Proprietari istituzionali (13F) 217 filer · $728.9M totale · Aggiornato al 30 Giugno 2026

Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.

Attività istituzionale — Q2 2026 vs trimestre precedente

Nuove posizioni	Posizioni chiuse	Aumentato	Diminuito	Variazione netta delle azioni
42 (+7 vs trimestre precedente)	64 (+28 vs trimestre precedente)	80 (-7 vs trimestre precedente)	47 (-16 vs trimestre precedente)	+5.4M

Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.

Istituzione	Valore	Azioni	% di 13F tracciati	Tipo
NOMURA ASSET MANAGEMENT INTERNATIONAL INC.	$71.566.000	3.184.974	9,82%	Azioni
Juniper Investment Company, LLC	$45.386.816	2.019.885	6,23%	Azioni
VANGUARD CAPITAL MANAGEMENT LLC	$45.043.789	2.004.619	6,18%	Azioni
FMR LLC	$41.871.497	1.863.440	5,74%	Azioni
STATE STREET CORP	$41.750.406	1.858.051	5,73%	Azioni
Ophir Asset Management Pty Ltd	$40.446.180	1.800.008	5,55%	Azioni
PERCEPTIVE ADVISORS LLC	$39.036.906	1.737.290	5,36%	Azioni
Conestoga Capital Advisors, LLC	$36.484.539	1.623.700	5,01%	Azioni
SILVERCREST ASSET MANAGEMENT GROUP LLC	$23.011.325	1.024.091	3,16%	Azioni
VANGUARD PORTFOLIO MANAGEMENT LLC	$22.205.281	988.219	3,05%	Azioni
GEODE CAPITAL MANAGEMENT, LLC	$21.427.261	953.365	2,94%	Azioni
DIMENSIONAL FUND ADVISORS LP	$20.062.856	892.873	2,75%	Azioni
CITADEL ADVISORS LLC	$17.701.821	787.798	2,43%	Azioni
YARGER WEALTH STRATEGIES, LLC	$15.278.432	634.223	2,10%	Azioni
ROYCE & ASSOCIATES LP	$14.364.667	639.282	1,97%	Azioni
WELLINGTON MANAGEMENT GROUP LLP	$11.702.264	520.795	1,61%	Azioni
Qube Research & Technologies Ltd	$10.704.820	476.405	1,47%	Azioni
FRED ALGER MANAGEMENT, LLC	$10.406.104	463.111	1,43%	Azioni
TWO SIGMA ADVISERS, LP	$9.974.907	218.700	1,37%	Azioni
D. E. Shaw & Co., Inc.	$9.846.714	438.216	1,35%	Azioni
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$9.183.579	408.704	1,26%	Azioni
Toroso Investments, LLC	$9.018.146	197.723	1,24%	Azioni
Soleus Capital Management, L.P.	$8.718.360	388.000	1,20%	Azioni
TWO SIGMA INVESTMENTS, LP	$8.702.159	387.279	1,19%	Azioni
Balyasny Asset Management L.P.	$8.584.686	382.051	1,18%	Azioni
GOLDMAN SACHS GROUP INC	$7.733.095	344.152	1,06%	Azioni
VANGUARD FIDUCIARY TRUST CO	$6.978.103	310.552	0,96%	Azioni
KENNEDY CAPITAL MANAGEMENT LLC	$6.611.371	294.231	0,91%	Azioni
UBS Group AG	$6.026.544	268.204	0,83%	Azioni
WASATCH ADVISORS LP	$5.726.929	156.388	0,79%	Azioni
BRIDGER MANAGEMENT, LLC	$4.855.373	132.588	0,67%	Azioni
Quantinno Capital Management LP	$4.497.191	200.142	0,62%	Azioni
AMERIPRISE FINANCIAL INC	$4.347.068	193.461	0,60%	Azioni
FIFTH THIRD BANCORP	$4.170.912	185.621	0,57%	Azioni
ORBIMED ADVISORS LLC	$3.932.250	175.000	0,54%	Azioni
Corient Private Wealth LP	$3.578.618	159.262	0,49%	Azioni
Public Sector Pension Investment Board	$3.298.304	146.787	0,45%	Azioni
Parkman Healthcare Partners LLC	$3.121.982	138.940	0,43%	Azioni
Universal- Beteiligungs- und Servicegesellschaft mbH	$2.879.149	128.133	0,40%	Azioni
VOLORIDGE INVESTMENT MANAGEMENT, LLC	$2.857.263	127.159	0,39%	Azioni
Summit Creek Advisors LLC	$2.704.354	120.354	0,37%	Azioni
CONNORS INVESTOR SERVICES INC	$2.700.445	120.180	0,37%	Azioni
BNP PARIBAS FINANCIAL MARKETS	$2.693.816	119.885	0,37%	Azioni
Bank of New York Mellon Corp	$2.522.415	112.257	0,35%	Azioni
RHUMBLINE ADVISERS	$2.373.280	105.621	0,33%	Azioni
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$2.303.872	102.531	0,32%	Azioni
XTX Topco Ltd	$2.173.905	96.747	0,30%	Azioni
Swiss National Bank	$1.914.444	85.200	0,26%	Azioni
BANK OF AMERICA CORP /DE/	$1.912.535	85.115	0,26%	Azioni
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	$1.875.420	51.213	0,26%	Azioni
LAZARD ASSET MANAGEMENT LLC	$1.875.301	83.458	0,26%	Azioni
RENAISSANCE TECHNOLOGIES LLC	$1.524.073	67.827	0,21%	Azioni
ALLIANCEBERNSTEIN L.P.	$1.522.477	41.575	0,21%	Azioni
Legal & General Group Plc	$1.468.954	65.374	0,20%	Azioni
CITIGROUP INC	$1.425.856	63.456	0,20%	Azioni
Squarepoint Ops LLC	$1.424.238	63.384	0,20%	Azioni
Russell Investments Group, Ltd.	$1.303.125	57.994	0,18%	Azioni
VICTORY CAPITAL MANAGEMENT INC	$1.193.157	53.100	0,16%	Azioni
ENVESTNET ASSET MANAGEMENT INC	$1.117.972	49.754	0,15%	Azioni
Sterling Capital Management LLC	$1.098.918	48.906	0,15%	Azioni
Sio Capital Management, LLC	$1.089.368	48.481	0,15%	Azioni
BOOTHBAY FUND MANAGEMENT, LLC	$1.010.521	44.972	0,14%	Azioni
PRUDENTIAL FINANCIAL INC	$995.219	44.291	0,14%	Azioni
WELLS FARGO & COMPANY/MN	$937.314	41.714	0,13%	Azioni
VANGUARD GROUP INC	$898.699	19.704	0,12%	Azioni
FIRST TRUST ADVISORS LP	$857.657	38.169	0,12%	Azioni
BlackRock, Inc.	$789.461	35.134	0,11%	Azioni
Zurcher Kantonalbank (Zurich Cantonalbank)	$738.274	32.856	0,10%	Azioni
Verition Fund Management LLC	$729.399	32.461	0,10%	Azioni
Aquatic Capital Management LLC	$712.771	31.721	0,10%	Azioni
Jain Global LLC	$680.908	30.303	0,09%	Azioni
JONES FINANCIAL COMPANIES LLLP	$662.072	28.042	0,09%	Azioni
Brevan Howard Capital Management LP	$652.461	29.037	0,09%	Azioni
VANGUARD ASSET MANAGEMENT, Ltd	$634.193	28.224	0,09%	Azioni
JANUS HENDERSON GROUP PLC	$623.335	17.038	0,09%	Azioni
MetLife Investment Management, LLC	$601.050	26.749	0,08%	Azioni
Y-Intercept (Hong Kong) Ltd	$600.735	26.735	0,08%	Azioni
Mariner, LLC	$570.520	25.390	0,08%	Azioni
TOCQUEVILLE ASSET MANAGEMENT L.P.	$561.750	25.000	0,08%	Azioni
Illinois Municipal Retirement Fund	$545.010	24.255	0,07%	Azioni
MANUFACTURERS LIFE INSURANCE COMPANY, THE	$516.855	23.002	0,07%	Azioni
Walleye Capital LLC	$490.408	21.825	0,07%	Azioni
Penn Capital Management Company, LLC	$489.689	21.793	0,07%	Azioni
ALLSTATE CORP	$483.240	21.506	0,07%	Azioni
EXCHANGE TRADED CONCEPTS, LLC	$476.948	21.226	0,07%	Azioni
MORGAN STANLEY	$476.588	21.210	0,07%	Azioni
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	$473.241	21.061	0,06%	Azioni
Louisiana State Employees Retirement System	$420.189	18.700	0,06%	Azioni
Invesco Ltd.	$409.628	18.230	0,06%	Azioni
DARK FOREST CAPITAL MANAGEMENT LP	$402.123	17.896	0,06%	Azioni
Vanguard Global Advisers, LLC	$371.384	16.528	0,05%	Azioni
Freestone Grove Partners LP	$328.219	14.607	0,05%	Azioni
NEW YORK STATE COMMON RETIREMENT FUND	$324.287	14.432	0,04%	Azioni
JOHNSON INVESTMENT COUNSEL INC	$307.008	13.663	0,04%	Azioni
Police & Firemen's Retirement System of New Jersey	$303.053	13.487	0,04%	Azioni
DIKER MANAGEMENT LLC	$303.000	13.500	0,04%	Azioni
OPPENHEIMER ASSET MANAGEMENT INC.	$284.672	12.669	0,04%	Azioni
GUGGENHEIM CAPITAL LLC	$283.302	12.608	0,04%	Azioni
ELEVATION POINT WEALTH PARTNERS, LLC	$263.303	11.718	0,04%	Azioni
Vestmark Advisory Solutions, Inc.	$263.303	11.718	0,04%	Azioni

Insider aziendali 49 insider · 27 dirigenti · 15 direttori

Insider	Ruolo	Ultima attività	Azioni possedute	Vendite 12m	Netto 12m
James P Mackin	President & CEO	06 Marzo 2025 M	865.283	0	$0
David Ashley Lee	Executive VP, COO & CFO	02 Marzo 2023 S	347.217	0	$0
Marshall S. Stanton	SVP, Clinical & MD Affair	17 Giugno 2025 S	64.200	0	$0
John E Davis	Chief Commercial Officer	11 Marzo 2025 M	208.778	0	$0
Amy Horton	VP, Chief Accounting Officer	06 Marzo 2025 S	146.651	0	$0
Matthew A Getz	VP, Human Resources	16 Agosto 2024 S	34.116	0	$0
Florian Tyrs	VP, Global Operations	27 Febbraio 2024 S	21.558	0	$0
Rochelle L. Maney	VP, Quality	26 Febbraio 2024 S	44.518	0	$0
Robert C Thomson	VP Research & Development	23 Febbraio 2024 A	13.291	0	$0
Dennis B Maier	SVP, Operations	06 Giugno 2023 S	34.724	0	$0
Franz Peter Barthold	VP, Research & Development	08 Novembre 2022 A	32.516	0	$0
Scott B Capps	VP, Clinical Research	12 Marzo 2021 F	153.203	0	$0
James M Mcdermid	SVP, CHRO	14 Marzo 2019 F	30.806	0	$0
Sherry M Saurini	VP, Quality	14 Marzo 2019 F	25.084	0	$0
William Robert Matthews	Senior VP, Operations, Quality	05 Marzo 2018 F	39.883	0	$0
David C Gale	VP, Research & Development	16 Novembre 2017 M	77.135	0	$0
Steven G Anderson	Former Executive Chairman	09 Aprile 2015 F	1.271.846	0	$0
Bruce G. Anderson	VP, US Sales &Global Marketing	07 Marzo 2015 F	42.106	0	$0
FRONK DAVID	VP, Regulatory Affairs	07 Marzo 2015 F	110.559	0	$0
David P. Lang	VP, Int'l Sales & Marketing	26 Febbraio 2015 A	73.441	0	$0
Jeffrey W Burris	Vice President & Gen. Counsel	15 Agosto 2014 M	95.221	0	$0
Gerald B Seery	Sr. VP, Sales and Marketing	30 Novembre 2012 S	71.999	0	$0
Albert E Heacox	Sr. VP Research and Devl	31 Dicembre 2011 F	110.144	0	$0
Philip A Theodore	VP, General Counsel	04 Settembre 2007 A	23.100	0	$0
Sidney B Ashmore	Vice President of Marketing	18 Gennaio 2006 M	42.728	0	$0
Kirby S Black	Sr. Vice President, R&D	21 Settembre 2004 M	55.131	0	$0
Vander James C Wyk	VP - Product Integrity	14 Settembre 2004 M	36.165	0	$0
Anthony B. Semedo	Direttore	02 Giugno 2026 J	6.325	0	$0
Elizabeth A Hoff	Direttore	22 Maggio 2025 A	31.389	0	$0
Marna P Borgstrom	Direttore	22 Maggio 2025 A	49.088	0	$0
Jon W Salveson	Direttore	22 Maggio 2025 A	129.840	0	$0
Jeffrey H Burbank	Direttore	22 Maggio 2025 A	53.796	0	$0
Daniel J Bevevino	Direttore	22 Maggio 2025 A	150.061	0	$0
Bullock James	Direttore	22 Maggio 2025 A	68.647	0	$0
Thomas F Ackerman	Direttore	22 Maggio 2025 A	149.896	0	$0
Harvey Morgan	Direttore	30 Agosto 2021 G	46.342	0	$0
Ronald D Mccall	Direttore	25 Agosto 2021 S	121.768	0	$0
Elkins C Ronald	Direttore	05 Settembre 2018 S	64.843	0	$0
James Benson	Direttore	02 Ottobre 2017 S	54.086	0	$0
John M Cook	Direttore	09 Giugno 2009 M	85.000	0	$0
LACY VIRGINIA C	Direttore	24 Aprile 2007 S	255.280	0	$0
VAN DYNE BRUCE J MD	Direttore	01 Agosto 2006 A	12.800	0	$0
OSS CAPITAL MANAGEMENT	Proprietario del 10%	31 Maggio 2007 S	1.918.000	0	$0
Lance A Berry	—	14 Agosto 2026 S	210.112	1	$-20.413
Andrew M Green	—	14 Agosto 2026 S	59.643	3	$-928.248
Jean F Holloway	—	12 Agosto 2026 S	184.118	1	$-27.835
Michael S Simpson	—	05 Marzo 2021 F	33.698	0	$0
Thomas J Bogenschuetz	—	05 Maggio 2020 A	23.451	0	$0
Thomas J Lynch	—	02 Novembre 2004 A	5.000	0	$0

Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato

Attivisti e proprietari del 5%+ 5 partecipazioni

Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.

Depositante	Depositato	Partecipazione	Stato	Scopo	Deposito
Juniper Targeted Opportunity Fund, L.P., Juniper HF Investors II, LLC, Juniper Targeted Opportunities, L.P., Juniper Targeted Opportunity Investors, LLC, Juniper Multi-Strategy Fund, L.P., Juniper HF Investors, LLC, Juniper Investment Company, LLC, Alexis P. Michas, John A. Bartholdson ×2 depositi	12 Agosto 2025	4,00%	Modifica	—	SEC
CryoLife, Inc., CL Falcon, Inc.	11 Maggio 2011	—	Deposito iniziale	M&A / vendita	SEC
Michael A. Roth and Brian J. Stark, as joint filers pursuant to Rule 13d-1(k)	10 Luglio 2007	—	Deposito iniziale	—	SEC
Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata	02 Dicembre 2005	—	Deposito iniziale	Investimento passivo	SEC
Persona segnalante non divulgata	18 Marzo 2005	—	Deposito iniziale	Investimento passivo	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Proprietà ETF Posseduti da 53 ETF

Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.

Fondo	Peso	Unità	Aggiornato al	Fonte
SAWS · ETF Series Solutions	2,95%	5.817 NS	30 Aprile 2026	N-PORT
HTEC · EXCHANGE TRADED CONCEPTS TRUST	1,77%	26.421 NS	30 Aprile 2026	N-PORT
PSCH · Invesco Exchange-Traded Fund Trust …	0,59%	37.075 SH	08 Agosto 2026	Giornaliero
RZG · Invesco Exchange-Traded Fund Trust	0,44%	22.725 SH	08 Agosto 2026	Giornaliero
SIXL · EXCHANGE TRADED CONCEPTS TRUST	0,25%	21.547 NS	31 Maggio 2026	N-PORT
ESSC · Strategy Shares	0,24%	1.691 NS	30 Aprile 2026	N-PORT
XSMO · Invesco Exchange-Traded Fund Trust	0,21%	246.008 SH	08 Agosto 2026	Giornaliero
IHI · iShares Trust	0,16%	202.161 SH	08 Agosto 2026	Giornaliero
IJT · iShares Trust	0,13%	397.869 SH	08 Agosto 2026	Giornaliero
FYC · First Trust Exchange-Traded AlphaDE…	0,11%	31.285 NS	30 Aprile 2026	N-PORT
VIOG · VANGUARD ADMIRAL FUNDS	0,10%	50.848 SH	08 Agosto 2026	Giornaliero
QVMS · Invesco Exchange-Traded Fund Trust …	0,08%	7.285 SH	08 Agosto 2026	Giornaliero
IWO · iShares Trust	0,08%	419.028 SH	08 Agosto 2026	Giornaliero
XJR · iShares Trust	0,07%	5.059 SH	08 Agosto 2026	Giornaliero
IJR · iShares Trust	0,06%	2.606.468 SH	08 Agosto 2026	Giornaliero
VTWG · VANGUARD SCOTTSDALE FUNDS	0,06%	49.054 SH	08 Agosto 2026	Giornaliero
VIOO · VANGUARD ADMIRAL FUNDS	0,05%	148.966 SH	08 Agosto 2026	Giornaliero
RSSL · Global X Funds	0,05%	18.968 NS	30 Aprile 2026	N-PORT
SAA · ProShares Trust	0,04%	505 NS	31 Maggio 2026	N-PORT
DFAS · Dimensional ETF Trust	0,04%	158.121 NS	30 Aprile 2026	N-PORT
IWM · iShares Trust	0,04%	1.162.604 SH	08 Agosto 2026	Giornaliero
ISCG · iShares Trust	0,04%	14.407 SH	08 Agosto 2026	Giornaliero
RWJ · Invesco Exchange-Traded Fund Trust …	0,04%	28.917 SH	08 Agosto 2026	Giornaliero
GSSC · Goldman Sachs ETF Trust	0,03%	14.525 NS	31 Maggio 2026	N-PORT
EBIT · Harbor ETF Trust	0,03%	101 NS	30 Aprile 2026	N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS	0,03%	263.046 SH	08 Agosto 2026	Giornaliero
SMDX · Tidal Trust III	0,03%	999 NS	30 Aprile 2026	N-PORT
PRFZ · Invesco Exchange-Traded Fund Trust	0,03%	27.103 SH	08 Agosto 2026	Giornaliero
ITWO · ProShares Trust	0,02%	2.057 NS	31 Maggio 2026	N-PORT
FHLC · FIDELITY COVINGTON TRUST	0,02%	18.392 NS	30 Aprile 2026	N-PORT
FAD · First Trust Exchange-Traded AlphaDE…	0,02%	2.917 NS	30 Aprile 2026	N-PORT
SCHA · SCHWAB STRATEGIC TRUST	0,02%	200.917 NS	31 Maggio 2026	N-PORT
ISCB · iShares Trust	0,02%	2.111 SH	08 Agosto 2026	Giornaliero
UWM · ProShares Trust	0,01%	1.609 NS	31 Maggio 2026	N-PORT
URTY · ProShares Trust	0,01%	1.624 NS	31 Maggio 2026	N-PORT
JSTC · Tidal Trust I	0,01%	1.526 NS	31 Maggio 2026	N-PORT
VXF · VANGUARD INDEX FUNDS	0,01%	495.296 SH	08 Agosto 2026	Giornaliero
VHT · VANGUARD WORLD FUND	0,01%	127.662 SH	08 Agosto 2026	Giornaliero
WSML · iShares Trust	0,01%	2.264 SH	08 Agosto 2026	Giornaliero
DFAC · Dimensional ETF Trust	0,01%	107.410 NS	30 Aprile 2026	N-PORT
MSSM · MORGAN STANLEY PATHWAY FUNDS	0,01%	1.773 NS	31 Maggio 2026	N-PORT
DCOR · Dimensional ETF Trust	0,00%	3.861 NS	30 Aprile 2026	N-PORT
HDG · ProShares Trust	0,00%	41 NS	31 Maggio 2026	N-PORT
DFSU · Dimensional ETF Trust	0,00%	1.937 NS	30 Aprile 2026	N-PORT
DFAU · Dimensional ETF Trust	0,00%	8.873 NS	30 Aprile 2026	N-PORT
DFUS · Dimensional ETF Trust	0,00%	12.377 NS	30 Aprile 2026	N-PORT
ITOT · iShares Trust	0,00%	61.883 SH	08 Agosto 2026	Giornaliero
IWV · iShares Trust	0,00%	10.738 SH	08 Agosto 2026	Giornaliero
SCHB · SCHWAB STRATEGIC TRUST	0,00%	25.635 NS	31 Maggio 2026	N-PORT
TILT · FlexShares Trust	0,00%	636 NS	30 Aprile 2026	N-PORT
VTI · VANGUARD INDEX FUNDS	0,00%	1.463.340 SH	08 Agosto 2026	Giornaliero
VTHR · VANGUARD SCOTTSDALE FUNDS	0,00%	3.652 SH	08 Agosto 2026	Giornaliero
EBI · RBB Fund Trust	0,00%	3 NS	31 Maggio 2026	N-PORT

Informazioni su Artivion, Inc. Common Stock Panoramica della società da Wikipedia

AORT Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

AORT Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

Medie mobili e sovrapposizioni

Volume

Oscillatori

Momentum e tendenza

Performance decennale Andamento di ricavi, utile netto, margini e EPS

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

Dividendi Rendimento, payout ratio, storico dividendi, CAGR 5Y

AORT Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

Target Price a 12 Mesi

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

Ultime notizie Notizie recenti che menzionano questa società

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

Proprietari istituzionali (13F) 217 filer · $728.9M totale · Aggiornato al 30 Giugno 2026

Insider aziendali 49 insider · 27 dirigenti · 15 direttori

Attivisti e proprietari del 5%+ 5 partecipazioni

Proprietà ETF Posseduti da 53 ETF